APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Vaccine

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Selected research

Market Outlook & Growth Opportunities

Global BCG Vaccine Market Outlook and Growth Opportunities 2026

1 January 2026196 pages

Choose your research edition.

Industry ResearchBCG Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal BCG Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.

This report provides an overview of the global BCG Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of BCG Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents BCG Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the BCG Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

BCG Vaccine Segment by Company

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

Serum Institute of India

Intervax

GSBPL

BCG Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Vaccine Segment by Application

Hospitals

Clinics

Others

BCG Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global BCG Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions BCG Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify BCG Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze BCG Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the BCG Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global BCG Vaccine industry.

Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of BCG Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. BCG Vaccine Industry Trends Table 2. BCG Vaccine Industry Drivers Table 3. BCG Vaccine Industry Opportunities and Challenges Table 4. BCG Vaccine Industry Restraints Table 5. Global BCG Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global BCG Vaccine Revenue Share by Company (2021-2026) Table 7. Global BCG Vaccine Sales Volume by Company (MT) & (2021-2026) Table 8. Global BCG Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global BCG Vaccine Average Price (USD/Kg) of Company (2021-2026) Table 10. Global BCG Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global BCG Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global BCG Vaccine Company, Product Type & Application Table 13. Global BCG Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global BCG Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immune BCG Table 18. Significant Companies of Therapy BCG Table 19. Global BCG Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global BCG Vaccine Sales Volume by Type (2021-2026) & (MT) Table 21. Global BCG Vaccine Sales Volume by Type (2027-2032) & (MT) Table 22. Global BCG Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global BCG Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global BCG Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global BCG Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global BCG Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global BCG Vaccine Sales Value Share by Type (2021-2026) Table 28. Global BCG Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global BCG Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global BCG Vaccine Sales Volume by Application (2021-2026) & (MT) Table 34. Global BCG Vaccine Sales Volume by Application (2027-2032) & (MT) Table 35. Global BCG Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global BCG Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global BCG Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global BCG Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global BCG Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global BCG Vaccine Sales Value Share by Application (2021-2026) Table 41. Global BCG Vaccine Sales Value Share by Application (2027-2032) Table 42. Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global BCG Vaccine Sales by Region (2021-2026) & (MT) Table 44. Global BCG Vaccine Sales Market Share by Region (2021-2026) Table 45. Global BCG Vaccine Sales by Region (2027-2032) & (MT) Table 46. Global BCG Vaccine Sales Market Share by Region (2027-2032) Table 47. Global BCG Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global BCG Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global BCG Vaccine Sales Value Share by Region (2021-2026) Table 50. Global BCG Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global BCG Vaccine Sales Value Share by Region (2027-2032) Table 52. Global BCG Vaccine Market Average Price (USD/Kg) by Region (2021-2026) Table 53. Global BCG Vaccine Market Average Price (USD/Kg) by Region (2027-2032) Table 54. Global BCG Vaccine Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 55. Global BCG Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global BCG Vaccine Sales by Country (2021-2026) & (MT) Table 57. Global BCG Vaccine Sales Market Share by Country (2021-2026) Table 58. Global BCG Vaccine Sales by Country (2027-2032) & (MT) Table 59. Global BCG Vaccine Sales Market Share by Country (2027-2032) Table 60. Global BCG Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global BCG Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global BCG Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global BCG Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 67. Merck BCG Vaccine Product Portfolio Table 68. Merck Recent Development Table 69. Sanofi Pasteur Company Information Table 70. Sanofi Pasteur Business Overview Table 71. Sanofi Pasteur BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 72. Sanofi Pasteur BCG Vaccine Product Portfolio Table 73. Sanofi Pasteur Recent Development Table 74. Japan BCG Lab Company Information Table 75. Japan BCG Lab Business Overview Table 76. Japan BCG Lab BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 77. Japan BCG Lab BCG Vaccine Product Portfolio Table 78. Japan BCG Lab Recent Development Table 79. China National Biotec Company Information Table 80. China National Biotec Business Overview Table 81. China National Biotec BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 82. China National Biotec BCG Vaccine Product Portfolio Table 83. China National Biotec Recent Development Table 84. Serum Institute of India Company Information Table 85. Serum Institute of India Business Overview Table 86. Serum Institute of India BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 87. Serum Institute of India BCG Vaccine Product Portfolio Table 88. Serum Institute of India Recent Development Table 89. Intervax Company Information Table 90. Intervax Business Overview Table 91. Intervax BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 92. Intervax BCG Vaccine Product Portfolio Table 93. Intervax Recent Development Table 94. GSBPL Company Information Table 95. GSBPL Business Overview Table 96. GSBPL BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 97. GSBPL BCG Vaccine Product Portfolio Table 98. GSBPL Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. BCG Vaccine Distributors List Table 102. BCG Vaccine Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. BCG Vaccine Product Image Figure 2. Global BCG Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global BCG Vaccine Sales (2021-2032) & (MT) Figure 5. Global BCG Vaccine Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global BCG Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immune BCG Image Figure 10. Therapy BCG Image Figure 11. Global BCG Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global BCG Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global BCG Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global BCG Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global BCG Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global BCG Vaccine Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global BCG Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global BCG Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global BCG Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global BCG Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global BCG Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global BCG Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 27. Global BCG Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global BCG Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global BCG Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America BCG Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America BCG Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe BCG Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe BCG Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific BCG Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific BCG Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America BCG Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America BCG Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa BCG Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa BCG Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt BCG Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt BCG Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt BCG Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. BCG Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. BCG Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Merck
  • Sanofi Pasteur
  • Japan BCG Lab
  • China National Biotec
  • Serum Institute of India
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global BCG Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global BCG Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global BCG Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 BCG Vaccine Market Dynamics
  1. 2.1 BCG Vaccine Industry Trends
  2. 2.2 BCG Vaccine Industry Drivers
  3. 2.3 BCG Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Vaccine Industry Restraints
3 BCG Vaccine Market by Company
  1. 3.1 Global BCG Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global BCG Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global BCG Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global BCG Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global BCG Vaccine Company Ranking (2024-2026)
  6. 3.6 Global BCG Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global BCG Vaccine Company Product Type and Application
  8. 3.8 Global BCG Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global BCG Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 BCG Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 BCG Vaccine Market by Type
  1. 4.1 BCG Vaccine Type Introduction
  2. 4.1.1 Immune BCG
  3. 4.1.2 Therapy BCG
  4. 4.2 Global BCG Vaccine Sales Volume by Type
  5. 4.2.1 Global BCG Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global BCG Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global BCG Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global BCG Vaccine Sales Value by Type
  9. 4.3.1 Global BCG Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global BCG Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global BCG Vaccine Sales Value Share by Type (2021-2032)
5 BCG Vaccine Market by Application
  1. 5.1 BCG Vaccine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global BCG Vaccine Sales Volume by Application
  6. 5.2.1 Global BCG Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global BCG Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global BCG Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global BCG Vaccine Sales Value by Application
  10. 5.3.1 Global BCG Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global BCG Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global BCG Vaccine Sales Value Share by Application (2021-2032)
6 BCG Vaccine Regional Sales and Value Analysis
  1. 6.1 Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global BCG Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global BCG Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global BCG Vaccine Sales by Region (2027-2032)
  5. 6.3 Global BCG Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global BCG Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global BCG Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global BCG Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global BCG Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America BCG Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America BCG Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe BCG Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe BCG Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific BCG Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific BCG Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America BCG Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America BCG Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa BCG Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa BCG Vaccine Sales Value Share by Country, 2025 VS 2032
7 BCG Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global BCG Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global BCG Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global BCG Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global BCG Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global BCG Vaccine Sales by Country (2027-2032)
  6. 7.4 Global BCG Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global BCG Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global BCG Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA BCG Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada BCG Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico BCG Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany BCG Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France BCG Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. BCG Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy BCG Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain BCG Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia BCG Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands BCG Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries BCG Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China BCG Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan BCG Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea BCG Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India BCG Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia BCG Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia BCG Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil BCG Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina BCG Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile BCG Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia BCG Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru BCG Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia BCG Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel BCG Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE BCG Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey BCG Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran BCG Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran BCG Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt BCG Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt BCG Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt BCG Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck BCG Vaccine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Japan BCG Lab
  14. 8.3.1 Japan BCG Lab Company Information
  15. 8.3.2 Japan BCG Lab Business Overview
  16. 8.3.3 Japan BCG Lab BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
  18. 8.3.5 Japan BCG Lab Recent Developments
  19. 8.4 China National Biotec
  20. 8.4.1 China National Biotec Company Information
  21. 8.4.2 China National Biotec Business Overview
  22. 8.4.3 China National Biotec BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 China National Biotec BCG Vaccine Product Portfolio
  24. 8.4.5 China National Biotec Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India BCG Vaccine Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 Intervax
  32. 8.6.1 Intervax Company Information
  33. 8.6.2 Intervax Business Overview
  34. 8.6.3 Intervax BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Intervax BCG Vaccine Product Portfolio
  36. 8.6.5 Intervax Recent Developments
  37. 8.7 GSBPL
  38. 8.7.1 GSBPL Company Information
  39. 8.7.2 GSBPL Business Overview
  40. 8.7.3 GSBPL BCG Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GSBPL BCG Vaccine Product Portfolio
  42. 8.7.5 GSBPL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 BCG Vaccine Value Chain Analysis
  2. 9.1.1 BCG Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 BCG Vaccine Sales Mode & Process
  6. 9.2 BCG Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 BCG Vaccine Distributors
  9. 9.2.3 BCG Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst